Preview

Meditsinskiy sovet = Medical Council

Advanced search
Fullscreen

For citations:


Laktionov KK, Reutova EV, Kruteleva SY, Antonova EY. Efficacy of lorlatinib in the treatment of ALK-positive non-small cell lung cancer patients with progression on crizotinib: personal experience. Meditsinskiy sovet = Medical Council. 2021;(20):62-67. (In Russ.) https://doi.org/10.21518/2079-701X-2021-20-62-67



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)